CLINICAL_TRIALS
trial_result
· 2011-06-08
Clinical Trial Update: CKD-828(80/2.5mg) Pharmacokinetic Study_2nd [Phase 1]
Summary
A Phase 1 pharmacokinetic study of CKD-828 (80/2.5 mg) in hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 1 | Status: COMPLETED